Carcinogensis

You have full text access to this OnlineOpen article

Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms

  1. Takuji Tanaka1,†,*,
  2. Hiroyuki Kohno1,
  3. Rikako Suzuki1,
  4. Kazuya Hata2,
  5. Shigeyuki Sugie1,
  6. Naoko Niho3,
  7. Katsuhisa Sakano3,
  8. Mami Takahashi3,
  9. Keiji Wakabayashi3

Article first published online: 27 JUL 2005

DOI: 10.1002/ijc.21282

Issue

International Journal of Cancer

International Journal of Cancer

Volume 118, Issue 1, pages 25–34, 1 January 2006

Additional Information

How to Cite

Tanaka, T., Kohno, H., Suzuki, R., Hata, K., Sugie, S., Niho, N., Sakano, K., Takahashi, M. and Wakabayashi, K. (2006), Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int. J. Cancer, 118: 25–34. doi: 10.1002/ijc.21282

Author Information

  1. 1

    Department of Oncologic Pathology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  2. 2

    BMR Laboratories, Sunplanet Co., Ltd., Kamiishidu, Gifu Japan

  3. 3

    Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan

  1. †

    Fax: +81-76-286-6926

*Department of Oncologic Pathology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

Publication History

  1. Issue published online: 26 OCT 2005
  2. Article first published online: 27 JUL 2005
  3. Manuscript Accepted: 26 APR 2005
  4. Manuscript Received: 9 FEB 2005

Funded by

  • Ministry of Health, Labour and Welfare of Japan
  • Ministry of Education, Culture, Sports, Science and Technology of Japan. Grant Number: 15592007
  • Kanazawa Medical University. Grant Number: C2004-4
  • High-Technology Center of Kanazawa Medical University. Grant Number: H2004-6

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (623K)

References

  • 1
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539–45.
  • 2
    Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003; 417: 3–11.
  • 3
    Szilagyi A. Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: rationale of dietary manipulation with emphasis on disaccharides. Can J Gastroenterol 1998; 12: 133–46.
  • 4
    Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003; 24: 353–62.
  • 5
    Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 1–5.
    Direct Link:
  • 6
    van der Woude CJ, Kleibeuker JH, Jansen PL, Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 2004; 9: 123–30.
  • 7
    Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694–702.
  • 8
    Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 2003; 94: 965–73.
    Direct Link:
  • 9
    Suzuki R, Kohno H, Sugie S, Tanaka T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in the mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci. 2004; 95: 721–7.
    Direct Link:
  • 10
    Suzuki R, Kohno H, Sugie S, Tanaka T. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 2005; 20: 483–92.
  • 11
    Kohno H, Suzuki R, Sugie S, Tanaka T. β-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1, 2-dimethylhydrazine and dextran sodium sulfate. Cancer Sci 2005; 96: 69–76.
    Direct Link:
  • 12
    Tanaka T, Suzuki R, Kohno H, Sugie S, Takahashi M, Wakabayashi K. Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine and dextran sodium sulfate in male ICR mice possess bgr;-catenin gene mutations and increase immunorectivity for bgr;-catenin, cyclooxygenase-2, and inducible nitric oxide synthase. Carcinogenesis 2005; 26: 229–38.
  • 13
    Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis associated neoplasia in the human: study of histopathology, beta-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000; 21: 757–68.
  • 14
    Cooper HS, Everley L, Chang W-C, Pfeeiffer G, Lee B, Murthy S, Clapper ML. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium–induced colitis. Gastroenterology 2001; 121: 1407–16.
  • 15
    Barbour KW, Davis T, White A, Baumann H, Berger FG. Haptoglobin, inflammation, and tumorigenesis in the MIN mouse. Redox Rep 2001; 6: 366–8.
  • 16
    Hansen-Petrik MB, McEntee MF, Jull B, Shi H, Zemel MB, Whelan J. Prostaglandin E2 protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in ApcMin/− mice. Cancer Res 2002; 62: 403–8.
  • 17
    Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 2000; 1470: M69–78.
  • 18
    Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183–8.
  • 19
    DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996; 110: 1295–62.
  • 20
    Hull MA, Booth JK, Tisbury A, Scott N, Bonifer C, Markham AF, Coletta PL. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br J Cancer 1999; 79: 1399–405.
  • 21
    Arroyo PL, Hatch-Pigott V, Mower HF, Cooney RV. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat Res 1992; 281: 193–202.
  • 22
    Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Washington, DC) 1991; 254: 1001–3.
  • 23
    Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998; 153: 587–98.
  • 24
    Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, Tanaka M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999; 70: 222–9.
    Direct Link:
  • 25
    Bing RJ, Miyataka M, Rich KA, Hanson N, Wang X, Slosser HD, Shi SR. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 2001; 7: 3385–92.
  • 26
    Takahashi M, Fukuda K, Ohata T, Sugimura T, Wakabayashi K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 1997; 57: 1233–7.
  • 27
    Rao CV, Kawamori T, Hamid R, Reddy BS. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 1999; 20: 641–4.
  • 28
    Ahn B, Ohshima H. Suppression of intestinal polyposis in ApcMin/+ mice by inhibiting nitric oxide production. Cancer Res. 2001; 61: 8357–60.
  • 29
    Scott DJ, Hull MA, Cartwright EJ, Lam WK, Tisbury A, Poulsom R, Markham AF, Bonifer C, Coletta PL. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the ApcMin/+ mouse. Gastroenterology 2001; 121: 889–99.
  • 30
    Mabley JG, Pacher P, Bai P, Wallace R, Goonesekera S, Virag L, Southan GJ, Szabo C. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways. Mutat Res 2004; 548: 107–16.
  • 31
    Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2001; 2: 149–56.
  • 32
    Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 2003; 34: 955–68.
  • 33
    Takahashi M, Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 2004; 95: 475–80.
    Direct Link:
  • 34
    Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276–85.
  • 35
    Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A 1995; 92: 5258–65.
  • 36
    Hussain SP, Hofseth LJ, Harris CC. Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. Lung Cancer 2001; 34: S7–S15.
  • 37
    Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159–70.
  • 38
    Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993; 329: 1982–7.
  • 39
    Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995; 31A: 1061–4.
  • 40
    Paulsen JE. Modulation by dietary factors in murine FAP models. Toxicol Lett 2000; 112–113: 403–9.
  • 41
    Yamada Y, Hata K, Hirose Y, Hara A, Sugie S, Kuno T, Yoshimi N, Tanaka T, Mori H. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult ApcMin/+ mice. Cancer Res 2002; 62: 6367–70.
  • 42
    Murata M, Kawanishi S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem Biophys Res Commun 2004; 316: 123–8.
  • 43
    Paulsen JE, Steffensen I-L, Loberg EM, Husoy T, Namork E, Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001; 61: 5010–5.
  • 44
    Steffensen I-L, Paulsen JE, Eide TJ, Alexander J. 2-Amino-1-methyl-6- phenylimidazo[4, 5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis (Lond.) 1997; 18: 1049–54.
  • 45
    Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974; 30: 505–13.
  • 46
    Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238–49.
  • 47
    Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T. Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 2002; 93: 133–42.
  • 48
    Mollersen L, Paulsen JE, Olstorn HB, Knutsen HK, Alexander J. Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice. Carcinogenesis 2004; 25: 149–53.
  • 49
    Zingarelli B, Szabo C, Salzman AL. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999; 45: 199–209.
  • 50
    Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994; 54: 5947–52.
  • 51
    Kitajima S, Takuma S, Morimoto M. Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. J Vet Med Sci 1999; 61: 67–70.
  • 52
    Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res 2001; 61: 3182–7.
  • 53
    Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 1993; 90: 7240–4.
  • 54
    Perez-Sala D, Lamas S. Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal 2001; 3: 231–48.
  • 55
    Takahashi M, Nakatsugi S, Sugimura T, Wakabayashi K. Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis 2000; 21: 1117–20.
  • 56
    Suzui M, Okuno M, Tanaka T, Nakagama H, Moriwaki H. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of β-catenin mutation. Cancer Lett 2002; 183: 31–41.
  • 57
    Muller O, Nimmrich I, Finke U, Friedl W, Hoffmann I. A β-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β-catenin germline mutations in FAP patients. Genes Chromosomes Cancer 1998; 22: 37–41.
    Direct Link:
  • 58
    Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton S, Kinzler K et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci. U S A. 1992; 89: 4452–6.
  • 59
    Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7–17.
  • 60
    Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000; 50: 3333–7.
  • 61
    Goodman JE, Hofseth LJ, Hussain SP, Harris CC. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004; 44: 3–9.
    Direct Link:
  • 62
    Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review). Int J Mol Med 1998; 2: 715–9.
  • 63
    Uthoff SM, Eichenberger MR, Lewis RK, Fox MP, Hamilton CJ, McAuliffe TL, Grimes HL, Galandiuk S. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 2001; 19: 803–10.
View Full Article (HTML) Get PDF (623K)